Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21937701 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma
Condition: Hodgkin Disease
Intervention: Drug: Lenalidomide

Indicates status has not been verified in more than two years